Patrangsit Healthcare Group Public Company Limited (PHG.BK)
- Previous Close
14.00 - Open
14.00 - Bid --
- Ask --
- Day's Range
14.00 - 14.10 - 52 Week Range
13.20 - 17.50 - Volume
21,404 - Avg. Volume
84,196 - Market Cap (intraday)
4.23B - Beta (5Y Monthly) --
- PE Ratio (TTM)
16.79 - EPS (TTM)
0.84 - Earnings Date --
- Forward Dividend & Yield 0.50 (3.55%)
- Ex-Dividend Date Apr 28, 2025
- 1y Target Est
21.00
Patrangsit Healthcare Group Public Company Limited operates hospitals in Thailand. The company offers physical therapy, pediatric, eye, psychiatry, child and adolescent psychiatry, dental, pediatric dental, pediatric dermatology, child development clinic, gastrointestinal and liver medicine, pediatric nervous system, orthopedic surgery, chest and heart surgery, general surgery, urology surgery, neurosurgery, obstetrics and gynecology, ear, nose, throat, internal medicine, gastrointestinal and liver medicine, neuro medicine, pulmonary and respiratory, cardiology, hematology, pediatric pulmonary and respiratory, skin, and hemodialysis services. It also provides pediatric dental, skin, gastrointestinal tract and liver, nervous systems, pulmonary and respiratory, pediatric allergy, heart disease, and kidney disease, as well as child development services; and health check-up services, radiology and laboratory, men's health services, gastrointestinal tract endoscopy, chemotherapy, and women oncology services. The company was incorporated in 1984 and is based in Pathum Thani, Thailand.
www.patrangsit.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: PHG.BK
View MorePerformance Overview: PHG.BK
Trailing total returns as of 4/23/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PHG.BK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PHG.BK
View MoreValuation Measures
Market Cap
4.20B
Enterprise Value
3.16B
Trailing P/E
16.67
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.85
Price/Book (mrq)
2.05
Enterprise Value/Revenue
1.39
Enterprise Value/EBITDA
7.69
Financial Highlights
Profitability and Income Statement
Profit Margin
11.10%
Return on Assets (ttm)
7.23%
Return on Equity (ttm)
12.56%
Revenue (ttm)
2.27B
Net Income Avi to Common (ttm)
252.24M
Diluted EPS (ttm)
0.84
Balance Sheet and Cash Flow
Total Cash (mrq)
1.05B
Total Debt/Equity (mrq)
0.37%
Levered Free Cash Flow (ttm)
146.82M